US2002127713A1PendingUtilityA1
Specific tolerance in transplantation
Priority: Nov 22, 1991Filed: Jun 29, 2001Published: Sep 12, 2002
Est. expiryNov 22, 2011(expired)· nominal 20-yr term from priority
Inventors:David Sachs
A61K 35/28A61K 39/001C07K 16/28A61K 39/39541A61P 37/00C07K 14/70539A61K 48/00A61K 35/26A61K 2035/122A61K 38/13A61K 40/50A61K 40/418A61K 40/22A61K 40/10
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In general, the invention features, a method of inducing tolerance in a recipient mammal, e.g., a human, of a first species to a tissue obtained from a mammal, e.g., a swine, e.g., a miniature swine, of a second species, which tissue expresses an MHC antigen, including inserting DNA encoding an MHC antigen of the second species into a bone marrow hematopoietic stem cell from the recipient mammal, and allowing the MHC antigen encoding DNA to be expressed in the recipient.
Claims
exact text as granted — not AI-modified1 . A method of inducing tolerance in a recipient mammal of a first species to a tissue obtained from a mammal of a second species, which tissue expresses an MHC antigen, said method comprising
inserting DNA encoding an MHC antigen of said second species into a bone marrow hematopoietic stem cell from said recipient mammal, and allowing said MHC antigen encoding DNA to be expressed in the recipient.
2 . The method of claim 1 , wherein said cell is removed from said recipient mammal prior to said insertion and returned to said recipient mammal after said insertion.
3 . The method of claim 1 , wherein said recipient is a human.
4 . The method of claim 1 , wherein said mammal is a swine.
5 . The method of claim 4 , wherein said swine is a miniature swine.
6 . The method of claim 1 , wherein said DNA is obtained from the individual mammal from which said tissue is obtained.
7 . The method of claim 1 , wherein said DNA is obtained from an individual mammal which is syngeneic to the individual mammal from which said tissue is obtained.
8 . The method of claim 1 , wherein said DNA is obtained from an individual mammal which is MHC identical to the individual mammal from which said tissue is obtained.
9 . The method of claim 1 , wherein said DNA comprises an MHC class I gene.
10 . The method of claim 1 , wherein said DNA comprises an MHC class II gene.
11 . The method of claim 1 , wherein said DNA is inserted into said cell by transduction.
12 . The method of claim 11 , wherein said DNA is inserted into said cell by a retrovirus.
13 . The method of claim 12 , wherein said DNA is recipient is a human and said retrovirus is a Moloney-based retrovirus.
14 . A method of inducing tolerance in a recipient mammal to a tissue obtained from a donor mammal of the same species, which tissue expresses an MHC antigen, said method comprising
inserting DNA encoding an MHC antigen of said donor into a bone marrow hematopoietic stem cell from said recipient mammal, and allowing said MHC antigen encoding DNA to be expressed in the recipient.
15 . The method of claim 14 , wherein said cell is removed from said recipient prior to said insertion and returned to said recipient after said insertion.
16 . The method of claim 14 , wherein said recipient is a human.
17 . The method of claim 14 , wherein said DNA comprises an MHC class I gene.
18 . The method of claim 14 , wherein said DNA comprises an MHC class II gene.
19 . The method of claim 14 , wherein said DNA is inserted into said cell by transduction.
20 . The method of claim 19 , wherein said DNA is inserted into said cell by a retrovirus.
21 . The method of claim 20 , wherein said retrovirus is a Moloney-based retrovirus.Join the waitlist — get patent alerts
Track US2002127713A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.